Thomas Olencki, DO

The James Cancer Center
Thomas Olencki

Clinical Expertise

  • Carcinoma, Renal Cell
  • Eye Cancers
  • Eye Cancers
  • Medical Oncology
  • Melanoma
  • Skin Cancers
Insurance Information



Make an Appointment


As a medical oncologist, I treat patients with kidney cancer and skin cancers such as melanoma, squamous cell, basal cell, Merkel cell and adnexal carcinomas. My clinical interests include participating in clinical trials for the development of targeted and immunologic therapy for kidney cancer and melanoma. I’m also a clinical professor of internal medicine for The Ohio State University.

I’m an active member of the Cytokine Working Group that develops biologic therapies for patients with melanoma and kidney cancer. I’m also a member of the National Comprehensive Cancer Network (NCCN) committees on non-prostate genitourinary and non-melanoma skin cancer.

In addition, I’m actively involved with the Melanoma Research Foundation’s Community United for Research and Education of Ocular Melanoma (CURE OM) and the International Rare Cancers Initiative (IRCI) ocular melanoma group.

Education and Background


  • Michigan State University

    East Lansing, MI


  • Medical Oncology

    Wayne State University Hospitals

    Detroit, MI

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine
  • American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

I see patients at

The James at Martha Morehouse Medical Plaza

2050 Kenny Road, Columbus, Ohio 43221


The James at Brain and Spine Hospital

300 West 10th Avenue, Columbus, Ohio 43210


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Olencki has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • Merck & Co., Inc.
Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type